×
Pour une meilleure utilisation, nous vous conseillons d’activer Javascript dans votre navigateur.
Recombinant IL-6R (Tocilizumab Biosimilar) anticorps
Research Grade
Reactivité: Humain
ELISA
Hôte: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
N° du produit ABIN7446060
Détail du produit anti-IL-6R (Tocilizumab Biosimilar) anticorps
(cache)
Antigène
Tous les produits IL-6R (Tocilizumab Biosimilar)
IL-6R (Tocilizumab Biosimilar)
Type d'anticorp
Recombinant Antibody
Reactivité
Humain
Hôte
Toutes les hôtes sur IL-6R (Tocilizumab Biosimilar) Anticorps
Mammalian Cells
Expression System
Mammalian cells
Clonalité
Toutes les clonalités sur IL-6R (Tocilizumab Biosimilar) Anticorps
Monoclonal
Conjugué
Tous les conjugués à travers IL-6R (Tocilizumab Biosimilar) Anticorps
Cet anticorp IL-6R (Tocilizumab Biosimilar) est non-conjugé
Application
Tous les applications à travers IL-6R (Tocilizumab Biosimilar) Anticorps.
ELISA
Fonction
Tocilizumab Biosimilar - Anti-IL-6R mAb
Attributs du produit
Antibody Type: IgG1Kappa
Purification
Recombinant antibody expressed in mammalien cells and purified.
Classe de qualité
Research Grade
Isotype
IgG1 kappa
Alternatives
(show)
Information d'application
(cache)
Restrictions
For Research Use only
Stockage
(cache)
Buffer
PBS pH 7.5
Stock
4 °C,-20 °C
Stockage commentaire
4°C for short term, -20°C for long term
Détails sur IL-6R (Tocilizumab Biosimilar)
(cache)
Antigène
IL-6R (Tocilizumab Biosimilar)
Abstract
IL-6R (Tocilizumab Biosimilar) Produits
Synonymes
anticorps CD126, anticorps IL-6R-1, anticorps IL-6RA, anticorps IL6Q, anticorps IL6RA, anticorps IL6RQ, anticorps gp80, anticorps interleukin 6 receptor, anticorps IL6R
Classe de substances
Biosimilar
Sujet
Tocilizumab Tocilizumab, also known as atlizumab, is a recombinant humanized, anti-human monoclonal antibody (mAb) of the immunoglobulin G1κ subclass directed against soluble and membrane-bound interleukin-6 (IL-6) receptor (IL-6R) which plays an important role in immune response and is implicated in the pathogenesis of many diseases, such as autoimmune diseases, multiple myeloma and prostate cancer.
Numéro CAS
375823-41-9
Vus récemment
(cache)